Cargando…
Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade De Odontologia De Bauru - USP
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393539/ https://www.ncbi.nlm.nih.gov/pubmed/28403359 http://dx.doi.org/10.1590/1678-77572016-0217 |
_version_ | 1783229568157483008 |
---|---|
author | GUZMÁN-URIBE, Daniela ALVARADO-ESTRADA, Keila Neri PIERDANT-PÉREZ, Mauricio TORRES-ÁLVAREZ, Bertha SÁNCHEZ-AGUILAR, Jesus Martin ROSALES-IBÁÑEZ, Raúl |
author_facet | GUZMÁN-URIBE, Daniela ALVARADO-ESTRADA, Keila Neri PIERDANT-PÉREZ, Mauricio TORRES-ÁLVAREZ, Bertha SÁNCHEZ-AGUILAR, Jesus Martin ROSALES-IBÁÑEZ, Raúl |
author_sort | GUZMÁN-URIBE, Daniela |
collection | PubMed |
description | Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissue-engineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. OBJECTIVE: The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral mucosa from diabetic subjects as a first step towards a possible clinical application for cases of diabetic foot. MATERIAL AND METHODS: Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal cells were isolated and cultured using autologous fibrin to develop dermal-epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized with collagen IV and cytokeratin 5-14 as specific markers. A Student´s t- test was performed to assess the differences between both groups. RESULTS: It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression of specific markers were observed and the cytokeratin 5-14 expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, showing a significant difference. CONCLUSION: Cells from oral mucosa could be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues. |
format | Online Article Text |
id | pubmed-5393539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Faculdade De Odontologia De Bauru - USP |
record_format | MEDLINE/PubMed |
spelling | pubmed-53935392017-04-21 Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects GUZMÁN-URIBE, Daniela ALVARADO-ESTRADA, Keila Neri PIERDANT-PÉREZ, Mauricio TORRES-ÁLVAREZ, Bertha SÁNCHEZ-AGUILAR, Jesus Martin ROSALES-IBÁÑEZ, Raúl J Appl Oral Sci Original Articles Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissue-engineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. OBJECTIVE: The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral mucosa from diabetic subjects as a first step towards a possible clinical application for cases of diabetic foot. MATERIAL AND METHODS: Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal cells were isolated and cultured using autologous fibrin to develop dermal-epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized with collagen IV and cytokeratin 5-14 as specific markers. A Student´s t- test was performed to assess the differences between both groups. RESULTS: It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression of specific markers were observed and the cytokeratin 5-14 expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, showing a significant difference. CONCLUSION: Cells from oral mucosa could be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues. Faculdade De Odontologia De Bauru - USP 2017 /pmc/articles/PMC5393539/ /pubmed/28403359 http://dx.doi.org/10.1590/1678-77572016-0217 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles GUZMÁN-URIBE, Daniela ALVARADO-ESTRADA, Keila Neri PIERDANT-PÉREZ, Mauricio TORRES-ÁLVAREZ, Bertha SÁNCHEZ-AGUILAR, Jesus Martin ROSALES-IBÁÑEZ, Raúl Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title | Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title_full | Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title_fullStr | Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title_full_unstemmed | Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title_short | Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
title_sort | oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393539/ https://www.ncbi.nlm.nih.gov/pubmed/28403359 http://dx.doi.org/10.1590/1678-77572016-0217 |
work_keys_str_mv | AT guzmanuribedaniela oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects AT alvaradoestradakeilaneri oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects AT pierdantperezmauricio oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects AT torresalvarezbertha oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects AT sanchezaguilarjesusmartin oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects AT rosalesibanezraul oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects |